President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Targeting European allies won't fix any of our problems with China, or improve health care, writes Josh Steuterman.

South Koreans’ perceptions of the US have taken a dive amid Trump’s ‘America First’ foreign policy and trade agenda.

Johnson & Johnson (NYSE:JNJ) is set to kick off the second quarter pharma earnings on Wednesday, with investors focusing on ...

Already late with carrying out his administration's prior threats around pharmaceutical tariffs, President Donald Trump has ...

Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...

Tariff Threats Prompt Expedited Pharmaceutical Shipments to U.S. March 27, 2025. Some drugmakers ... Pharmaceutical products have long been spared from trade wars due to the potential harms.

President Trump threatened as much as 200% tariffs on pharma Tuesday. By Wednesday morning, Wall Street had ignored the ...